GoldenGolden
Advanced Search
Kira Pharmaceuticals

Kira Pharmaceuticals

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

January 2021
Kira Pharmaceuticals raises a $53,500,000 series B round from APlus Partners, Foresite Capital, QiMing Venture Partners, Quan Capital, RA Capital Management and Vivo Capital.
November 2020
Kira Pharmaceuticals raises a $46,000,000 series A round from 6 Dimensions Capital, QiMing Venture Partners, Quan Capital and Sinopharm Capital.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Kira Pharmaceuticals
February 23, 2021
www.prnewswire.com:443
/PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated...
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.